Development of decellularized scaffolds for stem cell-driven tissue engineering

Journal of Tissue Engineering and Regenerative Medicine

Volumn 11, Issue 4, 2017, Pages 942-965

  Rana, Deepti ^a   Zreiqat, Hala ^b   Benkirane Jessel, Nadia ^c   Ramakrishna, Seeram ^d   Ramalingam, Murugan ^a,e  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Faculté de Médecine ^*  (France)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e TOHOKU UNIVERSITY   (Japan)

Author keywords

decellularization; organ transplantation; recellularization; regenerative medicine; scaffolds; stem cells; tissue engineering

Indexed keywords

CELL CULTURE; CELL ENGINEERING; CELL PROLIFERATION; COPYRIGHTS; FLUORIDATION; REGENERATIVE MEDICINE; SCAFFOLDS (BIOLOGY); TISSUE;

CELL DRIVEN; CONDITION; DECELLULARIZATION; DECELLULARIZED; EXTRACELLULAR MATRICES; ORGAN REPLACEMENT; RECELLULARIZATION; REGENERATIVE MEDICINE; STEM-CELL; TISSUES ENGINEERINGS;

STEM CELLS;

BONE TISSUE; CELL FATE; CELL FUNCTION; CELL INTERACTION; DECELLULARIZATION; EXTRACELLULAR MATRIX; HEART TISSUE; HUMAN; LUNG PARENCHYMA; NONHUMAN; REGENERATIVE MEDICINE; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; TISSUE ENGINEERING; TISSUE SCAFFOLD; TRACHEA TISSUE; ANIMAL; CELL COMMUNICATION; CHEMISTRY; CLINICAL TRIAL (TOPIC); CYTOLOGY; INSTRUMENT STERILIZATION; PROCEDURES;

ANIMALS; CELL COMMUNICATION; CLINICAL TRIALS AS TOPIC; HUMANS; STEM CELLS; STERILIZATION; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84933574458     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.2061     Document Type: Review

References (148)

1. ACell Inc., Columbia, MD, USA. 2014; MatriStem MicroMatrix®: https://acell.com/matristem-devices/matristem-product-list/
2. AlloDerm® Regenerative Tissue Matrix, LifeCell Corp., USA. 2014: http://www.lifecell.com/health-care-professionals/lifecell-products/allodermr-regenerative-tissue-matrix/
3. An G, Ji C, Wei Z et al. 2013; Engineering of corpus cavernosum using vascular endothelial growth factor-expressing muscle-derived stem cells seeded on acellular corporal collagen matrices. Urology 81: 424–431.
4. Anilkumar TV, Vineetha VP, Revi D et al. 2014; Biomaterial properties of cholecyst-derived scaffold recovered by a non-detergent/enzymatic method. J Biomed Mater Res B Appl Biomater 102: 1506–1516.
5. Aunins JG, Woodson BA, Hale TK et al. 1989; Effects of paddle impeller geometry on power input and mass transfer in small-scale animal cell culture vessels. Biotechnol Bioeng 34: 1127–1132.
6. Azhim A, Yamagami K, Muramatsu K et al. 2011; The use of sonication treatment to completely decellularize blood arteries: a pilot study. In Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, (EMBS): 2468–2471.
7. Azizi SA, Stokes D, Prockop DJ 1998; Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats – similarities to astrocyte grafts. Proc Natl Acad Sci U S A 95: 3908–3913.
8. B. Braun Melsungen AG, Germany. 2014; Lyoplant® biological, suturable dura substitution: http://www.bbraun.com/cps/rde/xchg/bbraun-com/hs.xsl/products.html?prid=PRID00000805
9. Badylak SF, Tullius R, Kokini K et al. 1995; The use of xenogeneic small intestinal submucosa as a biomaterial for Achille's tendon repair in a dog model. J Biomed Mater Res 29: 977–985.
10. Badylak SF, Weiss DJ, Caplan A et al. 2012; Engineered whole organs and complex tissues. Lancet 379: 943–952.
11. Badylak SF, Taylor D, Uygun K 2011; Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng 13: 27–53.
12. Baiguera S, Jungebluth P, Burns A et al. 2010; Tissue engineered human tracheas for in vivo implantation. Biomaterials 31: 8931–8938.
13. Baiguera S, Del Gaudio C, Kuevda E et al. 2014a; Dynamic decellularization and cross-linking of rat tracheal matrix. Biomaterials 35: 6344–6350.
14. Baiguera S, Del Gaudio C, Lucatelli E et al. 2014b; Electrospun gelatin scaffolds incorporating rat decellularized brain extracellular matrix for neural tissue engineering. Biomaterials 35: 1205–1214.
15. Baptista PM, Vyas D, Soker S. 2012; Liver regeneration and bioengineering – the emergence of whole organ scaffolds. In Liver Regeneration, Baptista PM (ed.). Intech: Croatia (Rijeka); 241–252.
16. Berg M, Ejnell H, Kovács A et al. 2014; Replacement of a tracheal stenosis with a tissue-engineered human trachea using autologous stem cells: a case report. Tissue Eng A 20: 389–397.
17. Bertanha M, Moroz A, Jaldin RG et al. 2014; Morphofunctional characterization of decellularized vena cava as tissue engineering scaffolds. Exp Cell Res 326: 103–111.
18. BiowelSciences, Islamabad, Pakistan. 2014; SureDerm Acellular Dermal Matrix: http://www.biowelsciences.com/we/?page_id=36
19. Bissell MJ, Aggeler J 1987; Dynamic reciprocity: how do extracellular matrix and hormones direct gene expression? Progr Clin Biol Res 249: 251–262.
20. Bolland F, Korossis S, Wilshaw SP et al. 2007; Development and characterisation of a full-thickness acellular porcine bladder matrix for tissue engineering. Biomaterials 28: 1061–1070.
21. Boyer RB, Sexton KW, Rodriguez-Feo CL et al. 2015; Adjuvant neurotrophic factors in peripheral nerve repair with chondroitin sulfate proteoglycan-reduced acellular nerve allografts. J Surg Res 193: 969–977.
22. Brennan EP, Reing J, Chew D et al. 2006; Antibacterial activity within degradation products of biological scaffolds composed of extracellular matrix. Tissue Eng 12: 2949–2955.
23. Brown B, Lindberg K, Reing J et al. 2006; The basement membrane component of biologic scaffolds derived from extracellular matrix. Tissue Eng 12: 519–526.
24. Brown BN, Freund JM, Han L et al. 2011; Comparison of three methods for the derivation of a biologic scaffold composed of adipose tissue extracellular matrix. Tissue Eng C Methods 17: 411–421.
25. Burch PT, Kaza AK, Lambert LM et al. 2010; Clinical performance of decellularized cryopreserved valved allografts compared with standard allografts in the right ventricular outflow tract. Ann Thorac Surg 90: 1301–1305.
26. Burns JS, Kristiansen M, Kristensen LP et al. 2011; Decellularized matrix from tumorigenic human mesenchymal stem cells promotes neovascularization with galectin-1 dependent endothelial interaction. PLoS One 6e21888: 1–17.
27. Caralt M, Uzarski JS, Iacob S et al. 2015; Optimization and critical evaluation of decellularization strategies to develop renal extracellular matrix scaffolds as biological templates for organ engineering and transplantation. Am J Transpl 15: 64–75.
28. Cebotari S, Lichtenberg A, Tudorache I et al. 2006; Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation 114: 1132–1137.
29. Cebotari S, Tudorache I, Ciubotaru A et al. 2011; Use of fresh decellularized allografts for pulmonary valve replacement may reduce the reoperation rate in children and young adults. Circulation 124: 115–123.
30. Clough A, Ball J, Smith GS et al. 2011; Porcine small intestine submucosa matrix (Surgisis) for esophageal perforation. Ann Thorac Surg 91: e15–16.
31. Cook Biotech Inc., USA. 2014; OASIS® Wound Matrix: http://www.cookbiotech.com/productinfo.php?product=oasis
32. CorMatrix ECM®. 2014; CorMatrix Inc., USA: http://www.cormatrix.com/
33. TM Surgical Implant: http://surgical.covidien.com/products/hernia-repair/permacol-surgical-implant
34. Cox B, Emili A 2006; Tissue subcellular fractionation and protein extraction for use in mass-spectrometry-based proteomics. Nat Protoc 1: 1872–1878.
35. Crapo PM, Gilbert TW, Badylak SF 2011; An overview of tissue and whole organ decellularization processes. Biomaterials 32: 3233–3243.
36. Chamberland C, Martinez-Fernandez A, Beraldi R et al. 2014; Embryonic decellularized cardiac scaffold supports embryonic stem cell differentiation to produce beating cardiac tissue. Stem Cells 2014: 10.
37. CryoLife Inc., Kennesaw, USA. 2014; SynerGraft® Technologies: http://www.cryolife.com/products/synergraft-technolo-gies
38. Cukierman E, Pankov R, Stevens DR et al. 2001; Taking cell–matrix adhesions to the third dimension. Sci (New York, NY) 294: 1708–1712.
39. Dahl SLM, Koh J, Prabhakar V et al. 2003; Decellularized native and engineered arterial scaffolds for transplantation. Cell Transpl 12: 659–666.
40. Daly KA, Stewart-Akers AM, Hara H et al. 2009; Effect of the αGal epitope on the response to small intestinal submucosa extracellular matrix in a nonhuman primate model. Tissue Eng A 15: 3877–3888.
41. De Peppo GM, Marcos-Campos I, Kahler DJ et al. 2013; Engineering bone tissue substitutes from human induced pluripotent stem cells. Proc Natl Acad Sci U S A 110: 8680–8685.
42. Deeken CR, White AK, Bachman SL et al. 2011; Method of preparing a decellularized porcine tendon using tributyl phosphate. J Biomed Mater Res B Appl Biomater 96B: 199–206.
43. DePuy Orthopaedics Inc., Warsaw, IN, USA. 2009; Restore Orthobiologic Soft Tissue Implant: http://www.acc.co.nz/PRD_EXT_CSMP/groups/external_communications/documents/reports_results/wpc096860.pdf
44. Dohmen PM, Lembcke A, Holinski S et al. 2007; Mid-term clinical results using a tissue-engineered pulmonary valve to reconstruct the right ventricular outflow tract during the Ross procedure. Ann Thorac Surg 84: 729–736.
45. Edwards Lifesciences Corp., USA. 2003; Carpentier–Edwards Perimount Pericardial Aortic Bioprosthesis: http://www.edwards.com/_layouts/edwards.moss.web.webapp/US_Product/Heart_valve/aortic.htm
46. Edwards Lifesciences Corp., USA. 2014; Edwards Prima Plus Stentless Porcine Bioprosthesis: http://www.edwards.com/products/porcinevalves/pages/primaplusstentless.aspx
47. Elliott MJ, De Coppi P, Speggiorin S et al. 2012; Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study. Lancet 380: 994–1000.
48. Evaristo TC, da CruzAlves FCM, Moroz A et al. 2014; Light-emitting diode effects on combined decellularization of tracheae. A novel approach to obtain biological scaffolds. Acta Cirurg Brasil 29: 485–492.
49. Fink DW 2009; FDA regulation of stem cell-based products. Sci (New York, NY) 324: 1662–1663.
50. Fitzpatrick E, Mitry RR, Dhawan A 2009; Human hepatocyte transplantation: state of the art. J Intern Med 266: 339–357.
51. Flynn LE 2010; The use of decellularized adipose tissue to provide an inductive microenvironment for the adipogenic differentiation of human adipose-derived stem cells. Biomaterials 31: 4715–4724.
52. Freytes DO, Badylak SF, Webster TJ et al. 2004; Biaxial strength of multilaminated extracellular matrix scaffolds. Biomaterials 25: 2353–2361.
53. Freytes DO, Stoner RM, Badylak SF 2008; Uniaxial and biaxial properties of terminally sterilized porcine urinary bladder matrix scaffolds. J Biomed Mater Res B Appl Biomater 84: 408–414.
54. Fröhlich M, Grayson WL, Marolt D et al. 2010; Bone grafts engineered from human adipose-derived stem cells in perfusion bioreactor culture. Tissue Eng A 16: 179–189.
55. Fung YC 1981; Biomechanics: Mechanical Properties of Living Tissues, Springer- Verlag: New York.
56. Gilbert TW 2012; Strategies for tissue and organ decellularization. J Cell Biochem 113: 2217–2222.
57. Gilbert TW, Sellaro TL, Badylak SF 2006; Decellularization of tissues and organs. Biomaterials 27: 3675–3683.
58. Gillies AR, Smith LR, Lieber RL et al. 2011; Method for decellularizing skeletal muscle without detergents or proteolytic enzymes. Tissue Eng C Methods 17: 383–389.
59. Go T, Jungebluth P, Baiguero S et al. 2010; Both epithelial cells and mesenchymal stem cell-derived chondrocytes contribute to the survival of tissue-engineered airway transplants in pigs. J Thorac Cardiovasc Surg 139: 437–443.
60. Gong J, Sagiv O, Cai H et al. 2008; Effects of extracellular matrix and neighboring cells on induction of human embryonic stem cells into retinal or retinal pigment epithelial progenitors. Exp Eye Res 86: 957–965.
61. Gray FL, Turner CG, Ahmed A et al. 2012; Prenatal tracheal reconstruction with a hybrid amniotic mesenchymal stem cells-engineered construct derived from decellularized airway. J Pediatr Surg 47: 1072–1078.
62. Gui L, Chan SA, Breuer CK et al. 2010; Novel utilization of serum in tissue decellularization. Tissue Eng C Methods 16: 173–184.
63. Gui L, Muto A, Chan SA et al. 2009; Development of decellularized human umbilical arteries as small-diameter vascular grafts. Tissue Eng A 15: 2665–2676.
64. Gulati AK 1988; Evaluation of acellular and cellular nerve grafts in repair of rat peripheral nerve. J Neurosurg 68: 117–123.
65. Guyette JP, Gilpin SE, Charest JM et al. 2014; Perfusion decellularization of whole organs. Nat Protoc 9: 1451–1468.
66. He F, Chen X, Pei M 2009; Reconstruction of an in vitro tissue-specific microenvironment to rejuvenate synovium-derived stem cells for cartilage tissue engineering. Tissue Eng A 15: 3809–3821.
67. He H, Liu X, Peng L et al. 2013; Promotion of hepatic differentiation of bone marrow mesenchymal stem cells on decellularized cell-deposited extracellular matrix. Biomed Res Int 2013: 406871.
68. Health Resources and Services Administration, US Department of Health and Human Services. 2014; Organ Procurement and Transplantation Network: http://optn.transplant.hrsa.gov/
69. Henderson PW, Nagineni VV, Harper A et al. 2010; Development of an acellular bioengineered matrix with a dominant vascular pedicle. J Surg Res 164: 1–5.
70. Hesse E, Kluge G, Atfi A et al. 2010; Repair of a segmental long bone defect in human by implantation of a novel multiple disc graft. Bone 46: 1457–1463.
71. Hopkinson A, Shanmuganathan VA, Gray T et al. 2008; Optimization of amniotic membrane (AM) denuding for tissue engineering. Tissue Eng C Methods 14: 371–381.
72. Huang JW, Xie MK, Zhang Y et al. 2014; Reconstruction of penile urethra with the three-dimensional porous bladder acellular matrix in a rabbit model. Urology 84: 1499–1505.
73. Hudson TW, Liu SY, Schmidt CE 2004; Engineering an improved acellular nerve graft via optimized chemical processing. Tissue Eng 10: 1346–1358.
74. Hung SH, Su CH, Lee FP et al. 2013; Larynx decellularization: combining freeze-drying and sonication as an effective method. J Voice 27: 289–294.
75. Hussein KH, Park KM, Teotia PK et al. 2013; Sterilization using electrolyzed water highly retains the biological properties in tissue-engineered porcine liver scaffold. Int J Artif Organs 36: 781–792.
76. Iop L, Renier V, Naso F et al. 2009; The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds. Biomaterials 30: 4104–4116.
77. IOP Ophthalmics, Costa Mesa, CA, USA. 2014; IOPatch Sclera Patch Graft: http://www.iopinc.com/store/tutoplast-sclera/
78. Ji R, Zhang N, You N et al. 2012; The differentiation of MSCs into functional hepatocyte-like cells in a liver biomatrix scaffold and their transplantation into liver-fibrotic mice. Biomaterials 33: 8995–9008.
79. Jiang WC, Cheng YH, Yen MH et al. 2014; Cryo-chemical decellularization of the whole liver for mesenchymal stem cells-based functional hepatic tissue engineering. Biomaterials 35: 3607–3617.
80. Kajbafzadeh A, Javan-Farazmand N, Monajemzadeh M et al. 2013; Determining the optimal decellularization and sterilization protocol for preparing a tissue scaffold of a human-sized liver tissue. Tissue Eng C Methods 19: 642–651.
81. Kang H, Peng J, Lu S et al. 2014; In vivo cartilage repair using adipose-derived stem cell-loaded decellularized cartilage ECM scaffolds. J Tissue Eng Regen Med 8: 442–453.
82. Karabekmez FE, Duymaz A, Moran SL 2009; Early clinical outcomes with the use of decellularized nerve allograft for repair of sensory defects within the hand. Hand (NY) 4: 245–249.
83. Katzman HE, Glickman MH, Schild AF et al. 2005; Multicenter evaluation of the bovine mesenteric vein bioprostheses for hemodialysis access in patients with an earlier failed prosthetic graft. J Am Coll Surg 201: 223–230.
84. TM Acellular Porcine Peritoneum, for plastic and reconstructive surgery: http://www.prnewswire.com/news-releases/kensey-nash-introduces-a-novel-biomaterial-meso-biomatrix-acellular-porcine-peritoneum-for-plastic-and-reconstructive-surgery-148714285.html
85. Kim SS, Sundback CA, Kaihara S et al. 2000; Dynamic seeding and in vitro culture of hepatocytes in a flow perfusion system. Tissue Eng 6: 39–44.
86. Konertz W, Dohmen PM, Liu J et al. 2005; Hemodynamic characteristics of the matrix P decellularized xenograft for pulmonary valve replacement during the Ross operation. J Heart Valve Dis 14: 78–81.
87. Lecht S, Stabler CT, Rylander AL et al. 2014; Enhanced reseeding of decellularized rodent lungs with mouse embryonic stem cells. Biomaterials 35: 3252–3262.
88. Lee MH, Arcidiacono JA, Bilek AM et al. 2010; Considerations for tissue-engineered and regenerative medicine product development prior to clinical trials in the United States. Tissue Eng B Rev 16: 41–54.
89. Leor J, Amsalem Y, Cohen S 2005; Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol Ther 105: 151–163.
90. TM Reconstructive Tissue Matrix: http://www.lifecell.com/health-care-professionals/lifecell-products/stratticetm-reconstructive-tissue-matrix/
91. Lin CH, Yang JR, Chiang NJ et al. 2014; Evaluation of decellularized extracellular matrix of skeletal muscle for tissue engineering. Int J Artif Organs 37: 546–555.
92. Lin P, Chan WC, Badylak SF et al. 2004; Assessing porcine liver-derived biomatrix for hepatic tissue engineering. Tissue Eng 10: 1046–1053.
93. Lopes SAV, da Costa FDA, de Paula JB et al. 2009; Decellularized heterografts versus cryopreserved homografts: experimental study in sheep model. Revist Brasil Cirurg Cardiovasc 24: 15–22.
94. Lu Q, Ganesan K, Simionescu DT et al. 2004; Novel porous aortic elastin and collagen scaffolds for tissue engineering. Biomaterials 25: 5227–5237.
95. Macchiarini P, Jungebluth P, Go T et al. 2008; Clinical transplantation of a tissue-engineered airway. Lancet 372: 2023–2030.
96. Moore MA, Samsell B, Wallis G et al. 2015; Decellularization of human dermis using non-denaturing anionic detergent and endonuclease: a review. Cell Tissue Bank 16: 249–259.
97. Marolt D, Campos IM, Bhumiratana S et al. 2012; Engineering bone tissue from human embryonic stem cells. Proc Natl Acad Sci U S A 109: 8705–8709.
98. Medtronic Life Line, Minneapolis, MN, USA. 2014; Hancock II Tissue Valve: http://www.medtronic.com/patients/heart-valve-disease/about-surgery/our-heart-valve-products/hancock-ii-tissue-valve/
99. Mentor Worldwide LLC, Santa Barbara, CA, USA. 2008; Neoform: http://www.trademarkia.com/neoform-78974713.html
100. Montoya CV, McFetridge PS 2009; Preparation of ex vivo-based biomaterials using convective flow decellularization. Tissue Eng C Methods 15: 191–200.
101. Nagaoka Y, Yamada H, Kimura T et al. 2014; Reconstruction of small diameter arteries using decellularized vascular scaffolds. J Med Dent Sci 61: 33–40.
102. Nakayama KH, Batchelder CA, Lee CI, et al. 2010; Decellularized rhesus monkey kidney as a three-dimensional scaffold for renal tissue engineering. Tissue Eng A 16: 2207–2216.
103. Nichols JE, Niles J, Riddle M et al. 2013; Production and assessment of decellularized pig and human lung scaffolds. Tissue Eng A 19: 2045–2062.
104. Oberwallner B, Brodarac A, Choi YH et al. 2014; Preparation of cardiac extracellular matrix scaffolds by decellularization of human myocardium. J Biomed Mater Res A 102: 3263–3272.
105. Organogenesis Inc., MA, USA. 2007; Bioresorbable Collagen Scaffold Placed Inside the Heart Revolutionizes Treatment: http://www.organogenesis.com/news/press-release-biostar-release-07092007.html
106. Organogenesis Inc., MA, USA. 2014; Organogenesis Inc. Living Technology, Company Profile: http://www.organogenesis.com/products/
107. Ott HC, Matthiesen TS, Goh SK et al. 2008; Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 14: 213–221.
108. Otti AG, Jaus MO, Barale D et al. 2014; The first tissue-engineered airway transplantation: 5-year follow-up results. Lancet 383: 238–244.
109. Paschos NK, Brown WE, Eswaramoorthy R et al. 2014; Advances in tissue engineering through stem cell-based co-culture. J Tissue Eng Regen Med 9: 488–503.
110. Patnaik SS, Wang B, Weed B. 2014; Decellularized scaffolds: concepts, methodologies, and applications in cardiac tissue engineering and whole-organ regeneration. In Tissue Regeneration: Where Nanostructure Meets Biology. World Scientific Publication Company: Singapore; 1–48.
111. Pei M, Zhang Y, Li J et al. 2013; Antioxidation of decellularized stem cell matrix promotes human synovium-derived stem cell-based chondrogenesis. Stem Cells Dev 22: 889–900.
112. Pei M, Li JT, Shoukry M et al. 2011; A review of decellularized stem cell matrix: a novel cell expansion system for cartilage tissue engineering. Eur Cells Mater 22: 333–343.
113. Petersen TH, Calle EA, Zhao L et al. 2010; Tissue-engineered lungs for in vivo implantation. Sci (New York, NY) 329: 538–541.
114. Phillips M, Maor E, Rubinsky B 2010; Nonthermal irreversible electroporation for tissue decellularization. J Biomech Eng 132: 091003.
115. Price AP, Godin LM, Domek A et al. 2015; Automated decellularization of intact, human-sized lungs for tissue engineering. Tissue Eng C Methods 21: 94–103.
116. Ramakrishna S, Murugan R, Kumar TSS et al. 2010; Biomaterials: A Nano Approach, CRC Press: Boca Raton, FL.
117. Rana D, SampathKumar TS, Ramalingam M 2014; Cell-laden hydrogels for tissue engineering. J Biomater Tissue Eng 4: 507–535.
118. Raya-Rivera AM, Esquiliano D, Fierro-Pastrana R et al. 2014; Tissue-engineered autologous vaginal organs in patients: a pilot cohort study. Lancet 384: 329–336.
119. Roberts TS, Drez D Jr, McCarthy W et al. 1991; Anterior cruciate ligament reconstruction using freeze-dried, ethylene oxide-sterilized, bone–patellar tendon–bone allografts. Two year results in 36 patients. Am J Sports Med 19: 35–41.
120. Robertson MJ, Dries-Devlin JL, Kren SM et al. 2014; Optimizing recellularization of whole decellularized heart extracellular matrix. PLoS One 9: e90406.
121. Ross EA, Abrahamson DR, St. John P et al. 2012; Mouse stem cells seeded into decellularized rat kidney scaffolds endothelialize and remodel basement membranes. Organogenesis 8: 49–55.
122. Ross EA, Williams MJ, Hamazaki T et al. 2009; Embryonic stem cells proliferate and differentiate when seeded into kidney scaffolds. J Am Soc Nephrol 20: 2338–2347.
123. Sart S, Ma T, Li Y 2014; Extracellular matrices decellularized from embryonic stem cells maintained their structure and signaling specificity. Tissue Eng A 20: 54–66.
124. Sawada K, Terada D, Yamaoka T et al. 2008; Cell removal with supercritical carbon dioxide for acellular artificial tissue. J Chem Technol Biotechnol 83: 943–949.
125. Schenke-Layland K, Vasilevski O, Opitz F et al. 2003; Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. J Struct Biol 143: 201–208.
126. Schmitt T, Fox PM, Woon CY et al. 2013; Human flexor tendon tissue engineering: in vivo effects of stem cell reseeding. Plastic Reconstruct Surg 132: 567–576e.
127. Sellaro TL, Ravindra AK, Stolz DB et al. 2007; Maintenance of hepatic sinusoidal endothelial cell phenotype in vitro using organ-specific extracellular matrix scaffolds. Tissue Eng 13: 2301–2310.
128. Sheridan WS, Grant OB, Duffy GP et al. 2014; The application of a thermoresponsive chitosan/β-GP gel to enhance cell repopulation of decellularized vascular scaffolds. J Biomed Mater Res B Appl Biomater 102: 1700–1710.
129. Shevchenko RV, James SL, James SE 2010; A review of tissue-engineered skin bioconstructs available for skin reconstruction. J R Soc Interface 7: 229–258.
130. Soto-Gutierrez A, Zhang L, Medberry C et al. 2011; A whole-organ regenerative medicine approach for liver replacement. Tissue Eng C Methods 17: 677–686.
131. TM Valve: http://br.sjm.com/produtos/valvula-sjm-epic
132. St. Jude Medical Inc., MO, USA. 2004; St. Jude Medical announces first North American implant of the SJM Epic Supra Valve following Canadian regulatory approval: http://phx.corporate-ir.net/phoenix.zhtml?c=73836&p=irol-newsArticle&ID=592343&highlight=
133. Stryker Corp., USA. 2007; TissueMend Soft Tissue Repair Matrix: http://www.stryker.com/en-us/products/Orthopaedics/SoftTissueRepair/index.htm
134. Sun WQ, Leung P 2008; Calorimetric study of extracellular tissue matrix degradation and instability after γ-irradiation. Acta Biomater 4: 817–826.
135. Synovis Orthopedic and Woundcare Inc., Irvine, CA, USA. 2012; OrthADAPT Bioimplant Surgical Mesh: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi__id=1676962
136. Uygun BE, Soto-Gutierrez A, Yagi H et al. 2010; Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 16: 814–820.
137. Vincentelli A, Wautot F, Juthier F et al. 2007; In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates? J Thorac Cardiovasc Surg 134: 424–432.
138. Wang Y, Bao J, Wu Q et al. 2015; Method for perfusion decellularization of porcine whole liver and kidney for use as a scaffold for clinical-scale bioengineering engrafts. Xenotransplantation 22: 48–61.
139. Weinand C, Jian WX, Peretti GM et al. 2009; Conditions affecting cell seeding onto three-dimensional scaffolds for cellular-based biodegradable implants. J Biomed Mater Res B Appl Biomater 91: 80–87.
140. Wright Medical Technology Inc., Arlington, USA. 2014; GraftJacket® Regenerative Tissue Matrix: http://www.wmt.com/softtissue/graftjacket_right.asp
141. Xu CC, Chan RW, Tirunagari N 2007; A biodegradable, acellular xenogeneic scaffold for regeneration of the vocal fold lamina propria. Tissue Eng 13: 551–566.
142. Yang M, Chen CZ, Wang XN et al. 2009; Favorable effects of the detergent and enzyme extraction method for preparing decellularized bovine pericardium scaffold for tissue engineered heart valves. J Biomed Mater Res B Appl Biomater 91: 354–361.
143. Zhou J, Ye X, Wang Z et al. 2014a; Development of decellularized aortic valvular conduit coated by heparin–SDF-1α multilayer. Ann Thorac Surg S0003-4975: 01737–01738.
144. Zhou J, Hu S, Ding J et al. 2013; Tissue engineering of heart valves: PEGylation of decellularized porcine aortic valve as a scaffold for in vitro recellularization. Biomed Eng Online 12: 87.
145. Zhou Q, Li L, Li J. 2014b; Stem cells with decellularized liver scaffolds in liver regeneration and their potential clinical applications. Liver Int 35: 687–694.
146. Zhang J, Li L 2008; Stem cell niche: microenvironment and beyond. J Biol Chem 283: 9499–9503.
147. Zimmer Dental Inc., Warsaw, IN, USA. 2014; CopiOs Pericardium: http://www.zimmerdental.com/Products/Regenerative/rg_puCopiOsPeriOverView.aspx
148. Zimmer Inc., UK. 2014; Zimmer® Collagen Repair Patch: http://www.zimmer.co.uk/en-GB/hcp/shoulder/product/collagen-repair-patch.jspx